The role of immunotherapy in the treatment of acute myeloblastic leukemia: from allogeneic bone marrow transplantation to the application of interleukin 2.
Prentice
H G
HG
Department of Hematology, Royal Free Hospital School of Medicine, London, U.K.
Macdonald
I D
ID
Hamon
M D
MD
D000818:Animals; D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease / Q000209:etiology; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D051379:Mice; D014184:Transplantation, Homologous
D007376:Interleukin-2